Extravasation Injury – A Complete Patient Guide

Overview

Extravasation injury occurs when medication, contrast material, or fluid that is being infused intravenously (IV) leaks out of the vein into the surrounding tissue. The leaked substance can irritate or damage skin, muscle, and sometimes deeper structures such as tendons or nerves.

• Who it affects: Anyone who receives an IV infusion can be at risk, but it is most common in hospitalized patients, oncology patients receiving chemotherapy, and individuals undergoing radiologic imaging that requires contrast.
• Prevalence: Reported rates vary widely because definitions differ, but studies estimate that 0.1–6 % of all peripheral IV infusions result in clinically significant extravasation. In oncology centers, the incidence of chemotherapy‑related extravasation ranges from 0.01–0.1 % per chemotherapy cycle (Mayo Clinic, 2023).
• Why it matters: Although many extravasations are mild and resolve with simple measures, severe injuries can lead to tissue necrosis, functional loss, and prolonged hospital stays.

Symptoms

The presentation depends on the volume of fluid leaked, the type of medication, and the anatomical site. Common signs and symptoms include:

• Pain or burning sensation at the infusion site – often the earliest clue.
• Swelling (edema) that may develop minutes to hours after the infusion.
• Redness (erythema) or a pink hue surrounding the catheter.
• Warmth or coolness compared with surrounding tissue.
• Blistering or vesicle formation – especially with vesicant chemotherapy agents (e.g., doxorubicin, vincristine).
• Skin discoloration ranging from pale (ischemia) to violaceous (bruising).
• Hardening (induration) of tissue, indicating inflammatory or fibrotic changes.
• Decreased range of motion if the injury involves a joint or tendon.
• Loss of sensation or tingling suggesting nerve involvement.
• Ulceration or necrosis in severe cases, usually appearing 24–72 hours after the event.

Symptoms may evolve; therefore, continuous monitoring of the infusion site during and after therapy is essential.

Causes and Risk Factors

Primary Causes

• Vesicant or irritant drugs – chemotherapeutic agents (e.g., anthracyclines, vinca alkaloids), hyperosmolar solutions, calcium channel blockers, and some antibiotics.
• Contrast media used for CT, MRI, or angiography can cause tissue irritation if extravasated.
• Mechanical factors – displacement or dislodgement of the catheter, puncture of the vein wall, or use of high‑pressure infusion pumps.

Risk Factors

• Fragile veins – common in elderly patients, children, or those with chronic illnesses.
• Previous chemotherapy or radiation that has damaged local vasculature.
• Premature or poor technique during catheter placement (e.g., multiple attempts, use of a too‑large gauge needle).
• Use of peripheral IVs for infusions that are ideally given via central lines (e.g., vesicant chemotherapy).
• Obesity – makes vein identification harder and increases movement of the catheter.
• Patient movement or agitation (common in pediatric patients or those with altered mental status).
• Coagulopathies or thrombocytopenia – increase the chance of bleeding into tissue, worsening leakage.
• Use of infusion pumps set at high pressures without appropriate alarms.

Diagnosis

Diagnosis is primarily clinical, based on observation of the infusion site and patient-reported symptoms. However, certain tools help define the extent of injury.

Clinical Assessment

• Visual inspection for swelling, erythema, blistering, or discoloration.
• Palpation to assess temperature, firmness, and tenderness.
• Range‑of‑motion testing if the site is near a joint.
• Documentation of infusion details (drug, concentration, volume, rate, catheter size, and site).

Imaging & Tests

• Ultrasound – can identify fluid collections, assess depth of extravasation, and rule out thrombosis.
• Fluoroscopic contrast studies – occasionally used when a radiopaque contrast agent is suspected to have leaked.
• MRI – rarely required, but useful for evaluating deep tissue involvement when surgical planning is considered.
• Laboratory tests – baseline renal function and coagulation profile are checked before initiating high‑risk infusions, not for diagnosis of extravasation itself.

Treatment Options

Management depends on the type of agent, volume extravasated, time elapsed, and severity of tissue injury.

Immediate Measures (first 30‑60 minutes)

1. Stop the infusion immediately.
2. Leave the catheter in place (do not withdraw) to allow aspiration of any residual drug.
3. Aspirate gently with a syringe; up to 5–10 mL may be removed, decreasing tissue exposure.
4. Elevate the affected limb to reduce swelling.
5. Apply appropriate compressive measures:
   • Cold compress (10–15 min) for vesicants that cause inflammation.
   • Warm compress (10–15 min) for non‑vesicant irritants or when vasodilation may aid drug dispersion.
6. Document the event thoroughly.

Pharmacologic Interventions

• Antidotes for specific agents:
  • Doxorubicin/epirubicin – topical or infiltrative administration of dexrazoxane (500 mg/m² IV over 30 min, then 200 mg/m² over 24 h and 24 h later) within 6 hours is FDA‑approved (NIH, 2022).
  • Vinca alkaloids – hyaluronidase 150 U injected around the periphery of the lesion.
  • Taxanes, etoposide – no specific antidote; supportive care is primary.
• Analgesics – Acetaminophen or NSAIDs for mild pain; opioids for severe pain.
• Topical antibiotics – Prevent secondary infection if the skin is broken.

Procedural Options

• Hyaluronidase injection – breaks down hyaluronic acid, increasing dispersion of extravasated fluid; common for non‑vesicant agents.
• Surgical debridement – Required for full‑thickness necrosis or compartment syndrome.
• Negative pressure wound therapy (NPWT) – May aid healing of large ulcerations.

Supportive & Long‑Term Measures

• Physical therapy to maintain joint mobility when injuries involve extremities.
• Scar management: silicone gel sheets, pressure garments, or laser therapy once the wound has healed.
• Psychological support – severe injuries can cause anxiety or depression, especially in cancer patients.

Living with Extravasation Injury

Most patients recover fully with timely care, but daily lifestyle adjustments can promote healing and prevent recurrence.

Wound Care

• Keep the area clean; use mild soap and water.
• Apply prescribed dressings—hydrocolloid or foam dressings are often recommended for partial‑thickness wounds.
• Change dressings per nursing instructions, usually every 24–48 hours.

Activity Modifications

• Avoid heavy lifting or repetitive motions that stress the injured limb for 1–2 weeks.
• Perform gentle range‑of‑motion exercises as advised by a physical therapist.
• Use protective padding (e.g., soft splints) if the site is prone to accidental pressure.

Pain Management

• Take scheduled analgesics rather than waiting for pain to become severe.
• Consider topical lidocaine patches for localized discomfort.

Monitoring for Complications

• Watch for increasing redness, swelling, fever, or foul odor – signs of infection.
• Track changes in sensation (numbness, tingling) that could indicate nerve compromise.
• Report any new ulceration or tissue breakdown promptly.

Prevention

Prevention is a shared responsibility among healthcare providers, patients, and caregivers.

Best Practices for Clinicians

1. Choose the most appropriate vascular access: use a central line for vesicant chemotherapy or high‑osmolar solutions.
2. Assess vein quality before cannulation; prefer larger peripheral veins in the forearm over small dorsal hand veins.
3. Secure catheters with sterile dressings and verify secure placement before starting infusion.
4. Set infusion pumps to appropriate pressures and enable alarm limits.
5. Educate staff on early signs of extravasation and institute a rapid response protocol.

Patient & Caregiver Education

• Inspect the IV site every 15 minutes during infusion (more frequently for vesicants).
• Report any pain, burning, or swelling immediately.
• Avoid moving the limb excessively while the catheter is in place.
• Keep the infusion arm elevated unless contraindicated.

Complications

If extravasation is not recognized promptly or is inadequately managed, several serious complications can arise.

• Skin necrosis – tissue death that may require surgical excision and grafting.
• Compartment syndrome – increased pressure within a muscle compartment, potentially leading to permanent loss of function; a surgical emergency.
• Chronic pain and neuropathy – especially with nerve‑adjacent extravasation.
• Functional impairment – loss of range of motion or strength in the affected limb.
• Infection – secondary cellulitis or abscess formation.
• Psychological impact – anxiety, depression, and reduced quality of life, particularly in oncology patients.

When to Seek Emergency Care

References

• Mayo Clinic. “Extravasation (intravenous infiltration)”. Updated 2023. https://www.mayoclinic.org
• Cleveland Clinic. “Chemotherapy Extravasation Management”. 2022.
• National Institutes of Health. “Dexrazoxane for Anthracycline Extravasation”. 2022.
• American Society of Clinical Oncology (ASCO). “Guidelines for Peripheral Intravenous Access”. 2021.
• World Health Organization. “Safe Injection Practices”. 2020.
• U.S. Centers for Disease Control and Prevention. “Infusion Therapy Standards”. 2021.